BM
Bill Maughan Clear Street Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
12
Avg Return
Past Year
Past Year
25%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
84.6%
Neutral
15.4%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $130 |
58%
upside
| 2 | +55% |
0
%
| 10 Mar ‘26 3 months ago |
|
|
|
Buy
Maintained
| $28 |
211%
upside
| 1 | -22% |
0
%
| 3 Mar ‘26 3 months ago |
|
|
|
Buy
Upgraded
| $18 |
54%
upside
| 2 | -28% |
0
%
| 19 Feb ‘26 3 months ago |
|
|
|
Buy
Initiated
| $13 |
683%
upside
| 1 | +36% |
0
%
| 2 Feb ‘26 4 months ago |
|
|
|
Buy
Initiated
| $9 |
189%
upside
| 1 | -26% |
0
%
| 23 Dec ‘25 5 months ago |
|
|
|
Buy
Maintained
| $47 |
683%
upside
| 2 | +51% |
0
%
| 9 Dec ‘25 6 months ago |
|
|
|
Buy
Initiated
| $17 |
266%
upside
| 1 | +42% |
0
%
| 2 Dec ‘25 6 months ago |
|
|
|
Hold
Downgraded
| $8.60 |
0%
downside
| 1 | – |
–
| 6 Aug ‘25 10 months ago |
|
|
|
Buy
Initiated
| $190 |
41%
downside
| 1 | +82% |
0
%
| 1 Jul ‘25 11 months ago |
|
|
|
Hold
Downgraded
| $45 |
14%
downside
| 1 | – |
–
| 27 Jun ‘25 11 months ago |
|